316 related articles for article (PubMed ID: 35698353)
41. Chitosan-Based Anti-Oxidation Delivery Nano-Platform: Applications in the Encapsulation of DHA-Enriched Fish Oil.
Chang PK; Tsai MF; Huang CY; Lee CL; Lin C; Shieh CJ; Kuo CH
Mar Drugs; 2021 Aug; 19(8):. PubMed ID: 34436309
[TBL] [Abstract][Full Text] [Related]
42. In vitro cellular localization and efficient accumulation of fluorescently tagged biomaterials from monodispersed chitosan nanoparticles for elucidation of controlled release pathways for drug delivery systems.
Hassan UA; Hussein MZ; Alitheen NB; Yahya Ariff SA; Masarudin MJ
Int J Nanomedicine; 2018; 13():5075-5095. PubMed ID: 30233174
[TBL] [Abstract][Full Text] [Related]
43. Preparation, characterization, and Staphylococcus aureus biofilm elimination effect of baicalein-loaded tyrosine/hyaluronic acid/β-cyclodextrin-grafted chitosan nano-delivery system.
Tang L; Zhang Z; Ding W; Tang J; Deng X; He Q; Kong X; Chen J; Truong TMH; Wang G; Zhu X; Ding W
Int J Biol Macromol; 2024 Jan; 254(Pt 3):128066. PubMed ID: 37963503
[TBL] [Abstract][Full Text] [Related]
44. Synergistic antimicrobial action of chitosan-neem extracts nanoformulation as a promising strategy for overcoming multi-drug resistant bacteria.
Almowallad SJ; Alqahtani LS
Int J Biol Macromol; 2024 Jun; 272(Pt 1):132337. PubMed ID: 38797302
[TBL] [Abstract][Full Text] [Related]
45. Polyelectrolyte Complex Nanoparticles from Chitosan and Acylated Rapeseed Cruciferin Protein for Curcumin Delivery.
Wang F; Yang Y; Ju X; Udenigwe CC; He R
J Agric Food Chem; 2018 Mar; 66(11):2685-2693. PubMed ID: 29451796
[TBL] [Abstract][Full Text] [Related]
46. Incorporation of lysozyme into cellulose nanocrystals stabilized β-chitosan nanoparticles with enhanced antibacterial activity.
Zhang H; Feng M; Chen S; Shi W; Wang X
Carbohydr Polym; 2020 May; 236():115974. PubMed ID: 32172828
[TBL] [Abstract][Full Text] [Related]
47.
Yousefi M; Mohammadi VG; Shadnoush M; Khorshidian N; Mortazavian AM
Food Sci Technol Int; 2022 Oct; 28(7):592-602. PubMed ID: 34515555
[No Abstract] [Full Text] [Related]
48. Synthesis of rifaximin loaded chitosan-alginate core-shell nanoparticles (Rif@CS/Alg-NPs) for antibacterial applications.
Kumar D; Kumar S; Kumar S; Rohatgi S; Kundu PP
Int J Biol Macromol; 2021 Jul; 183():962-971. PubMed ID: 33965483
[TBL] [Abstract][Full Text] [Related]
49. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
[TBL] [Abstract][Full Text] [Related]
50. Dual-drug delivery of Ag-chitosan nanoparticles and phenytoin via core-shell PVA/PCL electrospun nanofibers.
Mohamady Hussein MA; Guler E; Rayaman E; Cam ME; Sahin A; Grinholc M; Sezgin Mansuroglu D; Sahin YM; Gunduz O; Muhammed M; El-Sherbiny IM; Megahed M
Carbohydr Polym; 2021 Oct; 270():118373. PubMed ID: 34364617
[TBL] [Abstract][Full Text] [Related]
51. Chitosan-based nanoparticles as delivery-carrier for promising antimicrobial glycolipid biosurfactant to improve the eradication rate of
Arif M; Sharaf M; Samreen ; Khan S; Chi Z; Liu CG
J Biomater Sci Polym Ed; 2021 Apr; 32(6):813-832. PubMed ID: 33428545
[TBL] [Abstract][Full Text] [Related]
52. Chitosan/sodium tripolyphosphate nanoparticles as efficient vehicles for antioxidant peptidic fraction from common kilka.
Hosseini SF; Soleimani MR; Nikkhah M
Int J Biol Macromol; 2018 May; 111():730-737. PubMed ID: 29337105
[TBL] [Abstract][Full Text] [Related]
53. Sustainable antimicrobial modified chitosan and its nanoparticles hydrogels: Synthesis and characterization.
Ahmed ME; Mohamed HM; Mohamed MI; Kandile NG
Int J Biol Macromol; 2020 Nov; 162():1388-1397. PubMed ID: 32777418
[TBL] [Abstract][Full Text] [Related]
54. Preparation, Characterization, and Antibacterial Effects of Chitosan Nanoparticles Embedded with Essential Oils Synthesized in an Ionic Liquid Containing System.
Wu J; Shu Q; Niu Y; Jiao Y; Chen Q
J Agric Food Chem; 2018 Jul; 66(27):7006-7014. PubMed ID: 29878760
[TBL] [Abstract][Full Text] [Related]
55. New trimethyl chitosan-based composite nanoparticles as promising antibacterial agents.
El-Sherbiny I; Salih E; Reicha F
Drug Dev Ind Pharm; 2016; 42(5):720-9. PubMed ID: 26289003
[TBL] [Abstract][Full Text] [Related]
56. Hybrid chitosan-lipid nanoparticles of green tea extract as natural anti-cellulite agent with superior
Abosabaa SA; Arafa MG; ElMeshad AN
Drug Deliv; 2021 Dec; 28(1):2160-2176. PubMed ID: 34623203
[TBL] [Abstract][Full Text] [Related]
57. Insights into chitosan antibiofilm activity against methicillin-resistant Staphylococcus aureus.
Costa EM; Silva S; Tavaria FK; Pintado MM
J Appl Microbiol; 2017 Jun; 122(6):1547-1557. PubMed ID: 28370752
[TBL] [Abstract][Full Text] [Related]
58. Screening of ionically crosslinked chitosan-tripolyphosphate microspheres using Plackett-Burman factorial design for the treatment of intrapocket infections.
Yadav SK; Khan G; Bansal M; Vardhan H; Mishra B
Drug Dev Ind Pharm; 2017 Nov; 43(11):1801-1816. PubMed ID: 28673095
[TBL] [Abstract][Full Text] [Related]
59. Chitosan derivatives co-delivering nitric oxide and methicillin for the effective therapy to the methicillin-resistant S. aureus infection.
Liu S; Cai X; Xue W; Ma D; Zhang W
Carbohydr Polym; 2020 Apr; 234():115928. PubMed ID: 32070544
[TBL] [Abstract][Full Text] [Related]
60. Chitosan-based nitric oxide-releasing dressing for anti-biofilm and in vivo healing activities in MRSA biofilm-infected wounds.
Choi M; Hasan N; Cao J; Lee J; Hlaing SP; Yoo JW
Int J Biol Macromol; 2020 Jan; 142():680-692. PubMed ID: 31622708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
